Literature DB >> 21847052

The Masaoka-Koga stage classification for thymic malignancies: clarification and definition of terms.

Frank C Detterbeck1, Andrew G Nicholson, Kazuya Kondo, Paul Van Schil, Cesar Moran.   

Abstract

Entities:  

Mesh:

Year:  2011        PMID: 21847052     DOI: 10.1097/JTO.0b013e31821e8cff

Source DB:  PubMed          Journal:  J Thorac Oncol        ISSN: 1556-0864            Impact factor:   15.609


× No keyword cloud information.
  98 in total

1.  Circulating miR-21-5p and miR-148a-3p as emerging non-invasive biomarkers in thymic epithelial tumors.

Authors:  Teresa Bellissimo; Emanuele Russo; Federica Ganci; Carmen Vico; Andrea Sacconi; Flavia Longo; Domenico Vitolo; Marco Anile; Daniele Disio; Mirella Marino; Giovanni Blandino; Federico Venuta; Francesco Fazi
Journal:  Cancer Biol Ther       Date:  2016       Impact factor: 4.742

Review 2.  The 2015 World Health Organization Classification of Tumors of the Thymus: Continuity and Changes.

Authors:  Alexander Marx; John K C Chan; Jean-Michel Coindre; Frank Detterbeck; Nicolas Girard; Nancy L Harris; Elaine S Jaffe; Michael O Kurrer; Edith M Marom; Andre L Moreira; Kiyoshi Mukai; Attilio Orazi; Philipp Ströbel
Journal:  J Thorac Oncol       Date:  2015-10       Impact factor: 15.609

3.  Multilobulated thymoma with an acute angle: a new predictor of lung invasion.

Authors:  Daniel B Green; Sarah Eliades; Alan C Legasto; Gulce Askin; Jeffrey L Port; James F Gruden
Journal:  Eur Radiol       Date:  2019-02-26       Impact factor: 5.315

4.  Prognostic stratification of thymic epithelial tumors based on both Masaoka-Koga stage and WHO classification systems.

Authors:  Geun Dong Lee; Hyeong Ryul Kim; Se Hoon Choi; Yong-Hee Kim; Dong Kwan Kim; Seung-Il Park
Journal:  J Thorac Dis       Date:  2016-05       Impact factor: 2.895

5.  Imaging of the thymus in myotonic dystrophy type 1.

Authors:  Andrea Mignarri; Francesco Gentili; Francesco Masia; Angelo Genua; Silvia Cenciarelli; Paola Brunori; Maria Antonietta Mazzei; Alessandro Malandrini; Antonio Federico; Francesco Giuseppe Mazzei; Maria Teresa Dotti
Journal:  Neurol Sci       Date:  2017-11-25       Impact factor: 3.307

6.  Clinical Outcomes of Second-Line Chemotherapy in Patients with Previously Treated Advanced Thymic Carcinoma: A Retrospective Analysis of 191 Patients from the NEJ023 Study.

Authors:  Kazunari Tateishi; Ryo Ko; Takehito Shukuya; Yusuke Okuma; Satoshi Watanabe; Shoichi Kuyama; Kyoko Murase; Yoko Tsukita; Hironori Ashinuma; Taku Nakagawa; Kazutsugu Uematsu; Mika Nakao; Yoshiaki Mori; Kyoichi Kaira; Atsuto Mouri; Takao Miyabayashi; Hiroyuki Sakashita; Yoko Matsumoto; Tomoyuki Tanigawa; Tomonobu Koizumi; Satoshi Morita; Kunihiko Kobayashi; Toshihiro Nukiwa; Kazuhisa Takahashi
Journal:  Oncologist       Date:  2019-11-26

7.  Computed Tomography Features associated With the Eighth Edition TNM Stage Classification for Thymic Epithelial Tumors.

Authors:  Sukhmani K Padda; Donato Terrone; Lu Tian; Amanda Khuong; Joel W Neal; Jonathan W Riess; Mark F Berry; Chuong D Hoang; Bryan M Burt; Ann N Leung; Erich J Schwartz; Joseph B Shrager; Heather A Wakelee
Journal:  J Thorac Imaging       Date:  2018-05       Impact factor: 3.000

Review 8.  Pediatric thymomas: report of two cases and comprehensive review of the literature.

Authors:  Annabelle L Fonseca; Doruk E Ozgediz; Emily R Christison-Lagay; Frank C Detterbeck; Michael G Caty
Journal:  Pediatr Surg Int       Date:  2013-12-10       Impact factor: 1.827

9.  Paraneoplastic Morvan's syndrome following surgical treatment of recurrent thymoma: A case report.

Authors:  Edvina Galié; Rosaria Renna; Domenico Plantone; Andrea Pace; Mirella Marino; Bruno Jandolo; Tatiana Koudriavtseva
Journal:  Oncol Lett       Date:  2016-07-29       Impact factor: 2.967

10.  Thymic carcinomas: clinicopathologic study of 37 cases from a single institution.

Authors:  Vincent Thomas de Montpréville; Maria-Rosa Ghigna; Ludovic Lacroix; Benjamin Besse; Philippe Broet; Philippe Dartevelle; Elie Fadel; Peter Dorfmuller
Journal:  Virchows Arch       Date:  2013-01-15       Impact factor: 4.064

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.